Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 86 Results

Intervention Indication Therapeutic Area Year Actions
Lecanemab for treating early Alzheimer's disease Lecanemab (BAN2401) Alzheimer's disease Neurology 2021 View  |  Download
Lenti‐D for adrenoleukodystrophy in boys Elivaldogene tavalentivec (Lenti-D) Adrenoleukodystrophy (ALD) Genetic Disorders , Neurology 2017 View  |  Download
Leriglitazone for X-linked andrenoleukodystrophy Leriglitazone (MIN-102) X-linked adrenoleukodystrophy (X-ALD) Endocrine Nutritional and Metabolic Disorders , Genetic Disorders , Neurology 2023 View  |  Download
Levodopa, carbidopa monohydrate and entacapone intestinal gel for severe motor fluctuations in advanced Parkinson’s Disease Carbidopa (carbidopa monohydrate) , Entacapone (Comtess; OR-611) , Levodopa (ND0612; Inbrija; CVT-30) Parkinson's disease Neurology 2021 View  |  Download
Levosimendan for respiratory function in amyotrophic lateral sclerosis Levosimendan (OR1259; Simdax; Leximda) Respiratory dysfunction Neurology , Respiratory System 2020 View  |  Download
Masitinib with Riluzole for amyotrophic lateral sclerosis Masitinib , Riluzole Amyotrophic lateral sclerosis Neurology 2022 View  |  Download
Mexiletine for the Symptomatic Treatment of Myotonic Disorders – First Line Mexiletine hydrochloride (Namuscla) Myotonia Musculoskeletal System , Neurology 2018 View  |  Download
Mirabegron for neurogenic detrusor overactivity in people aged 3 to 17 years Mirabegron Neurogenic detrusor overactivity Neurology , Urology 2022 View  |  Download
Natalizumab (subcutaneous injection) for highly active relapsing remitting multiple sclerosis Natalizumab (BG00002; Tysabri; Antegren; AN-100226; ELND-002) Multiple sclerosis (MS) Neurology 2021 View  |  Download
Natalizumab biosimilar for treating relapsing-remitting multiple sclerosis Natalizumab biosimilar (PB006) Multiple sclerosis (MS) Neurology 2022 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications